
Arrange your collection
Choose your location, add the test to your care bag and select a time. If you are booking for someone else, assign the test to them in checkout.
Choose collection locationSTI & STD · Individual laboratory test
This qualitative PCR looks for hepatitis C RNA. It helps establish current infection after a positive hepatitis C antibody result.
Clinical authorDr Nirupama SabhapathySpecialist Clinical Pathology
Understanding the test
Also called Hepatitis C Viral RNA
HCV RNA is useful when checking whether a reactive antibody represents current infection. It may also be requested at a specified time after treatment.
HCV RNA can clarify whether a positive hepatitis C antibody result reflects current viraemia.
A clinician may request another RNA test at a particular interval after treatment.
Before your sample
No fast is necessary. For a post-treatment check, attend on the date set by your clinician and provide the date of the last antiviral dose.
The clinician takes blood from a vein into a tube that keeps it from clotting. The collection team sends the labelled specimen to the laboratory.
Smart Report
2 to 3 daysLaboratory turnaround
A detected result is evidence of current virus. Clinical timing matters for an undetected result after a recent exposure or during and after treatment.
From sample to follow-up

Choose your location, add the test to your care bag and select a time. If you are booking for someone else, assign the test to them in checkout.
Choose collection locationLook for HCV PCR Qualitative in your report. Use the sample type and collection time when comparing it with an earlier report.
Explore Smart Report
Record the timing of any treatment or recent exposure so the clinician can interpret detected or undetected RNA at the right stage.
Patient questions
Antibodies may stay detectable after a past infection has cleared or been treated. Your clinician considers timing, treatment and any recent exposure when interpreting RNA.
Yes. Very early after exposure the virus may not yet be detectable in the blood, so a single "Not Detected" result soon after a possible exposure may need repeating. Your doctor will advise when a repeat sample is most informative, based on when the exposure happened and your other results.
Yes, in two situations. Very early in an infection the virus can appear in the blood before antibodies have formed, and people whose immune response is impaired may not make detectable antibodies at all. In both cases PCR finds the virus that the antibody test misses, which is why your doctor may request it despite a negative antibody result.
The usual cure check is a sensitive quantitative HCV RNA test at least 12 weeks after the last dose of antiviral treatment. An undetectable result at the end of treatment alone does not establish cure. Ask your treating clinician which RNA test they have requested and when it is due.
KEEP EXPLORING
Open a package to see exactly which tests it includes.

A confidential 5-in-1 blood screen for the core blood-borne STIs: HIV (1 & 2), hepatitis B, hepatitis C and syphilis.

A 20-marker combined work-up pairing blood serology (HIV, hepatitis B & C, syphilis) with a 14-target genital PCR panel and urinalysis: a complete…

Our most comprehensive 28-target STI and genital-flora PCR panel, adding candida species, bacterial-vaginosis organisms and additional viruses on top…

A combined urine PCR package covering 45 named organism targets and 12 selected antibiotic-resistance genes, with clinician-led interpretation.
Choosing for a particular need?
We can help you read the options.
Your next step
Written by Dr Nirupama Sabhapathy, Specialist Clinical Pathology. Medically reviewed by Dr Joyce Jose, Specialist Clinical Pathology, on .
Catalogue information and AED price checked on 2 November 2026. Clinical suitability, preparation, collection arrangements and turnaround are confirmed for your selected test.